Jump to ContentJump to Main Navigation
Adverse EventsRace, Inequality, and the Testing of New Pharmaceuticals$
Users without a subscription are not able to see the full content.

Jill A. Fisher

Print publication date: 2020

Print ISBN-13: 9781479877997

Published to NYU Press Scholarship Online: January 2021

DOI: 10.18574/nyu/9781479877997.001.0001

Show Summary Details
Page of

PRINTED FROM NYU Press SCHOLARSHIP ONLINE (www.nyu.universitypressscholarship.com). (c) Copyright University of NYU Press Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in NYSO for personal use.date: 22 January 2022



The Social Inequality of Adverse Events

(p.253) Conclusion
Adverse Events

Jill A. Fisher

NYU Press

The book’s conclusion reflects on the political and economic context of US Phase I trials. A society characterized by deeply imbricated stigmas ensures that there will always be healthy volunteers willing to enroll in Phase I trials, whether these are the same or new participants who need the financial compensation. Ultimately, attending to the underlying social inequalities animating the Phase I industry is critical to understand what is at stake when healthy volunteers are used in drug development.

Keywords:   Phase I trials, healthy volunteers, social inequalities, imbricated stigma, United States, drug development, pharmaceutical industry

NYU Press Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.